93 related articles for article (PubMed ID: 16534225)
1. Oxysterols are increased in plasma of end-stage renal disease patients.
Siems W; Quast S; Peter D; Augustin W; Carluccio F; Grune T; Sevanian A; Hampl H; Wiswedel I
Kidney Blood Press Res; 2005; 28(5-6):302-6. PubMed ID: 16534225
[TBL] [Abstract][Full Text] [Related]
2. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
Boaz M; Iuliano L; Himmelfarb J; Matas Z; Micheletta F; McMonagle E; Friedman V; Natoli S; Gvirtz G; Biro A; Smetana S; Sabo G; Gafter U; Weinstein T
Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
[TBL] [Abstract][Full Text] [Related]
3. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
4. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Diepeveen SH; Verhoeven GH; van der Palen J; Dikkeschei BL; van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
Nephron Clin Pract; 2004; 98(1):c3-7. PubMed ID: 15361698
[TBL] [Abstract][Full Text] [Related]
6. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
9. Origin of oxysterols in hepatic bile of patients with biliary infection.
Yoshida T; Matsuzaki Y; Haigh WG; Fukushima S; Ikezawa K; Tanaka N; Lee SP
Am J Gastroenterol; 2003 Oct; 98(10):2275-80. PubMed ID: 14572579
[TBL] [Abstract][Full Text] [Related]
10. Relevance and mechanism of oxysterol stereospecifity in coronary artery disease.
Rimner A; Al Makdessi S; Sweidan H; Wischhusen J; Rabenstein B; Shatat K; Mayer P; Spyridopoulos I
Free Radic Biol Med; 2005 Feb; 38(4):535-44. PubMed ID: 15649656
[TBL] [Abstract][Full Text] [Related]
11. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
14. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
[TBL] [Abstract][Full Text] [Related]
16. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
17. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
18. [Effect of oxidative stress in patients with chronic renal failure].
González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
